“We are deeply concerned about the plight of COVID-19 in India, and our hearts go out to you, your loved ones and all the Indian people,” said Albert Bourla, Chairman and CEO of Pfizer.

The world’s leading pharma Pfizer sends its drugs worth $ 70 million (over ₹ 510 crore), from its distribution centers in the United States, Europe and Asia, which have been identified as part of India’s COVID-19 treatment protocol, Company President and CEO Albert Bourla said on May 3.

“We are deeply concerned about the plight of COVID-19 in India, and our hearts go out to you, your loved ones and all the Indian people,” he said in a letter sent to Pfizer India employees that ‘he shared on his linked.in post.

“We are committed to being a partner in India’s fight against this disease and are working quickly to mobilize the largest humanitarian relief effort in our company’s history,” said Bourla.

Currently, Pfizer colleagues in distribution centers in the United States, Europe and Asia are working hard to expedite shipments of Pfizer drugs that the Indian government has identified as part of its treatment protocol. COVID-19, he added.

“We are donating these drugs to make sure that every COVID-19 patient in every public hospital across the country can access the Pfizer drugs they need free of charge,” Bourla said.

These drugs, worth more than $ 70 million, will be made available immediately, and “we will work closely with the government and our NGO partners to get them where they are most needed,” he said. -he adds.

.